JRJ
GYRE icon

Jeffrey R. Jay’s Gyre Therapeutics GYRE Stock Holding History

Jeffrey R. Jay’s Portfolio GYRE Stock Details GYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$1.57M Buy
+467
New +$1.78M 1.24% 21

Other funds holding GYRE

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Jeffrey R. Jay's GYRE Position: Q2 2013 in Review

Jeffrey R. Jay opened a new position in Gyre Therapeutics (GYRE) in Q2 2013: 467 shares worth $1.57M. The stake represents 1.24% of the portfolio and ranks #21 among its holdings.

71 funds tracked by Wall St. Rank hold GYRE as of Q2 2013.

  • Jeffrey R. Jay held 467 shares of Gyre Therapeutics worth $1.57M as of Q2 2013.
  • Gyre Therapeutics was a new Jeffrey R. Jay position in Q2 2013.
  • Gyre Therapeutics made up 1.24% of Jeffrey R. Jay's portfolio in Q2 2013, its #21 holding.
  • 71 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q2 2013.

Based on Jeffrey R. Jay's 13F filing for Q2 2013, filed 14 Aug 2013.